Solazyme Receives Strategic Investment from Bunge in Series D Financing

Solazyme, Inc., a South San Francisco, CA-based industrial biotechnology company producing renewable oil and bioproducts from microalgae, announced that Bunge Limited (NYSE:BG), a global agribusiness and food company, has joined its Series D round as a strategic investor.
The investment will allow the two companies to collaborate at critical portions of a new value chain enabled by Solazyme’s sugar to oil technology platform. 
With approximately 32,000 employees in more than 30 countries, Bunge is one of the world’s largest originators and distributors of vegetable oils and one of the largest sugarcane processing companies in Brazil.
Commenting on the investment, Jonathan Wolfson, CEO and co-founder of Solazyme, said: “Bunge is a world-class organization with enormous expertise and capabilities in many of the markets Solazyme is targeting.
“Solazyme’s technology sits right at the intersection of Bunge’s substantial access to sugarcane and its key position in the worldwide natural oils markets.
“This, along with their operational and logistical capabilities, makes Bunge an ideal strategic investor”, he added.

Join the discussion